Effect of mesalamine and prednisolone on TNBS experimental colitis, following various doses of orally administered iron

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Triantafillidis, John K ^a   Douvi, Georgia ^a   Agrogiannis, George ^b   Patsouris, Efstratios ^b   Gikas, Aristofanis ^c   Papalois, Apostolos E ^d  

^a IASO GENERAL HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c Health Center of Kalivia   (Greece)

^d Experimental Research Center ELPEN   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; MALONALDEHYDE; MESALAZINE; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON MUCOSA; CONTROLLED STUDY; DRUG EFFECT; EOSINOPHIL; EXPERIMENTAL COLITIS; HISTOLOGY; MALE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; RAT; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION; ANIMAL; COLITIS; DIET SUPPLEMENTATION; DOSE RESPONSE; DRUG EFFECTS; INTESTINE MUCOSA; METABOLISM; ORAL DRUG ADMINISTRATION; PATHOLOGY; WISTAR RAT;

ADMINISTRATION, ORAL; ANIMALS; COLITIS; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; INTESTINAL MUCOSA; IRON; MALE; MALONDIALDEHYDE; MESALAMINE; PREDNISOLONE; RATS, WISTAR; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84901786188     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/648535     Document Type: Article

References (38)

1. Bergamaschi G., di Sabatino A., Albertini R., Ardizzone S., Biancheri P., Bonetti E., Cassinotti A., Cazzola P., Markopoulos K., Massari A., Rosti V., Porro G. B., Corazza G. R., Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor- α treatment. Haematologica 2010 95 2 199 205 2-s2.0-76549094518 10.3324/haematol.2009.009985
2. Lee T. W., Kolber M. R., Fedorak R. N., van Zanten S. V., Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: A systematic review and meta-analysis. Journal of Crohn's and Colitis 2012 6 3 267 275 2-s2.0-84858075234 10.1016/j.crohns.2011.09.010
3. Carrier J., Aghdassi E., Cullen J., Allard J. P., Iron supplementation increases disease activity and vitamin E ameliorates the effect in rats with dextran sulfate sodium-induced colitis. Journal of Nutrition 2002 132 10 3146 3150 2-s2.0-0036790056
4. Carrier J., Aghdassi E., Platt I., Cullen J., Allard J. P., Effect of oral iron supplementation on oxidative stress and colonic inflammation in rats with induced colitis. Alimentary Pharmacology and Therapeutics 2001 15 12 1989 1999 2-s2.0-0035659325 10.1046/j.1365-2036.2001.01113.x (Pubitemid 34014356)
5. Erichsen K., Milde A. M., Arslan G., Helgeland L., Gudbrandsen O. A., Ulvik R. J., Berge R. K., Hausken T., Berstad A., Low-dose oral ferrous fumarate aggravated intestinal inflammation in rats with DSS-induced colitis. Inflammatory Bowel Diseases 2005 11 8 744 748 2-s2.0-24644524039 10.1097/01.MIB.0000174374.83601.86 (Pubitemid 41271179)
6. Barollo M., D'Incà R., Scarpa M., Medici V., Cardin R., Bortolami M., Ruffolo C., Angriman I., Sturniolo G. C., Effects of iron manipulation on trace elements level in a model of colitis in rats. World Journal of Gastroenterology 2005 11 28 4396 4399 2-s2.0-23244444614 (Pubitemid 41093960)
7. Oldenburg B., van Berge Henegouwen G. P., Rennick D., van Asbeck B. S., Koningsberger J. C., Iron supplementation affects the production of pro-inflammatory cytokines in IL-10 deficient mice. European Journal of Clinical Investigation 2000 30 6 505 510 2-s2.0-0034074688 10.1046/j.1365-2362.2000. 00650.x (Pubitemid 30330464)
8. Knutson M. D., Walter P. B., Ames B. N., Viteri F. E., Both iron deficiency and daily iron supplements increase lipid peroxidation in rats. Journal of Nutrition 2000 130 3 621 628 2-s2.0-0034001883 (Pubitemid 30118081)
9. Reifen R., Nissenkorn A., Matas Z., Bujanover Y., 5-ASA and lycopene decrease the oxidative stress and inflammation induced by iron in rats with colitis. Journal of Gastroenterology 2004 39 6 514 519 2-s2.0-3242875823 (Pubitemid 38996892)
10. Minaiyan M., Mostaghel E., Mahzouni P., Preventive therapy of experimental colitis with selected iron chelators and anti-oxidants. International Journal of Preventive Medicine 2012 3 supplement 1 S162 S169
11. Bousvaros A., Zurakowski D., Duggan C., Law T., Rifai N., Goldberg N. E., Leichtner A. M., Vitamins A and E serum levels in children and young adults with inflammatory bowel disease: effect of disease activity. Journal of Pediatric Gastroenterology and Nutrition 1998 26 2 129 135 2-s2.0-0031910636 10.1097/00005176-199802000-00002 (Pubitemid 28078473)
12. Buffinton G. D., Doe W. F., Depleted mucosal antioxidant defences in inflammatory bowel disease. Free Radical Biology and Medicine 1995 19 6 911 918 2-s2.0-0028883592 10.1016/0891-5849(95)94362-H
13. Erichsen K., Hausken T., Ulvik R. J., Svardal A., Berstad A., Berge R. K., Ferrous fumarate deteriorated plasma antioxidant status in patients with Crohn disease. Scandinavian Journal of Gastroenterology 2003 38 5 543 548 2-s2.0-0038288676 10.1080/00365520310000771 (Pubitemid 36609862)
14. Erichsen K., Ulvik R. J., Nysaeter G., Johansen J., Ostborg J., Berstad A., Berge R. K., Hausken T., Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2005 40 9 1058 1065 2-s2.0-24744435535 10.1080/ 00365520510023198 (Pubitemid 41291355)
15. Gisbert J. P., Bermejo F., Pajares R., Pérez-Calle J.-L., Rodríguez M., Algaba A., Mancenido N., De La Morena F., Carneros J. A., McNicholl A. G., González-Lama Y., Maté J., Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement. Inflammatory Bowel Diseases 2009 15 10 1485 1491 2-s2.0-70349277116 10.1002/ibd.20925
16. de Silva A. D., Tsironi E., Feakins R. M., Rampton D. S., Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trial. Alimentary Pharmacology and Therapeutics 2005 22 11-12 1097 1105 2-s2.0-28844433694 10.1111/j.1365-2036.2005.02700.x (Pubitemid 41779517)
17. Seril D. N., Liao J., Yang G.-Y., Yang C. S., Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis 2003 24 3 353 362 2-s2.0-0037357426 10.1093/carcin/24.3. 353 (Pubitemid 36432628)
18. Triantafillidis J. K., Nasioulas G., Kosmidis P. A., Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Anticancer Research 2009 29 7 2727 2737 2-s2.0-69249161777
19. Geboes K., Riddell R., Öst A., Jensfelt B., Persson T., Löfberg R., A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut 2000 47 3 404 409 2-s2.0-0033849872 10.1136/gut.47.3.404
20. Triantafillidis J. K., Papalois A. E., Parasi A., Anagnostakis E., Burnazos S., Gikas A., Merikas E. G., Douzinas E., Karagianni M., Sotiriou H., Favourable response to subcutaneous administration of Infliximab in experimental colitis in rats. World Journal of Gastroenterology 2005 11 43 6843 6847 2-s2.0-30744440898 (Pubitemid 43092458)
21. Papalois A., Bonatsos V., Bouboulis G., Triantafillidis J., Triantafillidis J. K., Stanciu C., Experimental models of IBD: insights into pathogenesis of the disease. Inflammatory Bowel Disease: Pathogenesis, Clinical Manifestations, Diagnosis, Treatment 2012 Athens, Greece Technogramma 91 114
22. Menchén L. A., Colón A. L., Moro M. A., Leza J. C., Lizasoain I., Menchén P., Alvarez E., Lorenzo P., N-(3-(Aminomethyl) benzyl)acetamidine, an inducible nitric oxide synthase inhibitor, decreases colonic inflammation induced by trinitrobenzene sulphonic acid in rats. Life Sciences 2001 69 4 479 791 2-s2.0-0035876368 10.1016/S0024-3205(01)01139-0 (Pubitemid 32539389)
23. Neurath M. F., Fuss I., Pasparakis M., Alexopoulou L., Haralambous S., Meyer Zum Büschenfelde K.-H., Strober W., Kollias G., Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. European Journal of Immunology 1997 27 7 1743 1750 2-s2.0-0030818051 10.1002/eji.1830270722 (Pubitemid 27302858)
24. Fuss I. J., Marth T., Neurath M. F., Pearlstein G. R., Jain A., Strober W., Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice. Gastroenterology 1999 117 5 1078 1088 2-s2.0-0032718352 10.1016/S0016-5085(99)70392-6 (Pubitemid 29512666)
25. Breese E. J., Michie C. A., Nicholls S. W., Murch S. H., Williams C. B., Domizio P., Walker-Smith J. A., MacDonald T. T., Tumor necrosis factor α -producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 1994 106 6 1455 1466 2-s2.0-0028236232 (Pubitemid 24163114)
26. Buffinton G. D., Doe W. F., Depleted mucosal antioxidant defences in inflammatory bowel disease. Free Radical Biology and Medicine 1995 19 6 911 918 2-s2.0-0028883592 10.1016/0891-5849(95)94362-H
27. Reifen R., Matas Z., Zeidel L., Berkovitch Z., Bujanover Y., Iron supplementation may aggravate inflammatory status of colitis in a rat model. Digestive Diseases and Sciences 2000 45 2 394 397 2-s2.0-0034090320 10.1023/A:1005437331967 (Pubitemid 30133904)
28. Lih-Brody L., Powell S. R., Collier K. P., Reddy G. M., Cerchia R., Kahn E., Weissman G. S., Katz S., Floyd R. A., McKinley M. J., Fisher S. E., Mullin G. E., Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Digestive Diseases and Sciences 1996 41 10 2078 2086 2-s2.0-10344264959 10.1007/BF02093613 (Pubitemid 26366811)
29. Lin M., Rippe R. A., Niemelä O., Brittenham G., Tsukamoto H., Role of iron in NF- B activation and cytokine gene expression by rat hepatic macrophages. American Journal of Physiology: Gastrointestinal and Liver Physiology 1997 272 6 G1355 G1364 2-s2.0-0030858597
30. Aamodt G., Bukholm G., Jahnsen J., Moum B., Vatn M. H., Lygren I., Aubert E., Henriksen M., Flaaten B., Schultz T., Sauar J., Kjellevold Ø., Stray N., The association between water supply and inflammatory bowel disease based on a 1990-1993 cohort study in Southeastern Norway. American Journal of Epidemiology 2008 168 9 1065 1072 2-s2.0-54949098181 10.1093/aje/kwn218
31. Barollo M., D'Incà R., Scarpa M., Medici V., Cardin R., Fries W., Agriman I., Sturniolo G. C., Effects of iron deprivation or chelation on DNA damage in experimental colitis. International Journal of Colorectal Disease 2004 19 5 461 466 2-s2.0-4444296174 (Pubitemid 39193812)
32. Ablin J., Shalev O., Okon E., Deferiprone, an oral iron chelator, ameliorates experimental colitis and gastric ulceration in rats. Inflammatory Bowel Diseases 1999 5 4 253 261 2-s2.0-0033228705
33. Minaiyan M., Mostaghel E., Mahzouni P., Preventive therapy of experimental colitis with selected iron chelators and anti-oxidants. International Journal of Preventive Medicine 2012 3 supplement 1 S162 S169
34. Werner T., Wagner S. J., Martínez I., Walter J., Chang J.-S., Clavel T., Kisling S., Schuemann K., Haller D., Depletion of luminal iron alters the gut microbiota and prevents Crohn's disease-like ileitis. Gut 2011 60 3 325 333 2-s2.0-79851513757 10.1136/gut.2010.216929
35. Lund E. K., Wharf S. G., Fairweather-Tait S. J., Johnson I. T., Oral ferrous sulfate supplements increase the free radical-generating capacity of feces from healthy volunteers. American Journal of Clinical Nutrition 1999 69 2 250 255 2-s2.0-0032921725 (Pubitemid 29065547)
36. Soyars K. E., Fischer J. G., Iron supplementation does not affect cell proliferation or aberrant crypt foci development in the colon of Sprague-Dawley rats. Journal of Nutrition 1998 128 4 764 770 2-s2.0-0031944617 (Pubitemid 28158493)
37. Erichsen K., Ulvik R. J., Grimstad T., Berstad A., Berge R. K., Hausken T., Effects of ferrous sulphate and non-ionic iron-polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease. Alimentary Pharmacology and Therapeutics 2005 22 9 831 838 2-s2.0-27644588712 10.1111/j.1365-2036.2005.02652.x (Pubitemid 41564363)
38. Axelsson L.-G., Landström E., Bylund-Fellenius A.-C., Experimental colitis induced by dextran sulphate sodium in mice: beneficial effects of sulphasalazine and olsalazine. Alimentary Pharmacology and Therapeutics 1998 12 9 925 934 2-s2.0-0031681261 10.1046/j.1365-2036.1998.00357.x (Pubitemid 28428959)